This compound is a chiral azabicyclic molecule that serves as an active pharmaceutical intermediate. It contains an amine, a heterocyclic ring system, and a nitrile group, and is notable for its defined stereochemistry.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 866083-42-3
7-ethyl-10-hydroxycamptothecin
pharmaceutical raw material
(3aS,4S,6aR)-Tetrahydro-4-methoxy-furo[3,4-b]furan-2(3H)-one
pharmaceutical raw material
[(2R,3R,4R,5S,6S)-3,4,5-triacetyloxy-6-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]oxan-2-yl]methyl acetate
pharmaceutical raw material
Linsitinib
pharmaceutical raw material
(1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester
pharmaceutical intermediate
(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide
pharmaceutical raw material
(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide 2,2,2-trifluoroacetate
pharmaceutical intermediate
(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride
pharmaceutical intermediate
(1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-carbonitrile
ZQSMZFIOPBRRKZ-SRQIZXRXSA-N
C1[C@@H]2C[C@@H]2N[C@@H]1C#N
—